Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
114.71 USD | -0.54% | -0.94% | +5.22% |
11/09 | Merck: positive results for HPV vaccine | CF |
11/09 | Merck's HPV Vaccine Meets Main Goal in Phase 3 Study in Japanese Males | MT |
MarketScreener Strategies
Merck and Company : Leader in oncology, modest valuation | October 29, 2019 at 08:34 pm IST |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- MarketScreener Strategies
MarketScreener is also available in this country: United States.
Switch edition